Naturally scarce but synthetically accessible, Gauthier J.-P. Deblonde and Rebecca J. Abergel discuss element 89 and its emergence as a candidate radio-theranostic metal for cancer treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ferrier, M. G. et al. Nat. Commun. 7, 12312 (2016).
Castelvecchi, D. Nature http://doi.org/bq8s (2015).
Miederer, M., Scheinberg, D. A. & McDevitt, M. R. Adv. Drug Deliv. Rev. 60, 1371–1382 (2008).
McLaughlin, M. F. et al. PLOS One 8, e54531 (2013).
Pandya, D. N. et al. Theranostics 6, 698–709 (2016).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Deblonde, GP., Abergel, R. Active actinium. Nature Chem 8, 1084 (2016). https://doi.org/10.1038/nchem.2653
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchem.2653